Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologiesRasha A. Alshaikh, Katie B. Ryan, Christian Waeber|Advanced Drug Delivery Reviews|2022Cited by 107
Sphingosine 1-phosphate, a potential target in neovascular retinal diseaseRasha A. Alshaikh, Christian Waeber, Katie B. Ryan|British Journal of Ophthalmology|2021Cited by 20
Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic EfficacyRasha A. Alshaikh, Christian Waeber, Rania Gamal Eldin Zaki et al.|Journal of Pharmacology and Experimental Therapeutics|2023Cited by 6
In Vivo Ocular Pharmacokinetics and Toxicity of Siponimod in Albino RabbitsRasha A. Alshaikh, Katie B. Ryan, Rania A. Salah El Din et al.|Molecular Pharmaceutics|2024Cited by 1
Extended siponimod release <i>via</i> low-porosity PLGA fibres: a comprehensive three-month <i>in vitro</i> evaluation for neovascular ocular diseasesRasha A. Alshaikh, Katie B. Ryan, Krishnakumar Chullipalliyalil et al.|Biomaterials Science|2024Cited by 1